Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jul 28, 2017; 9(21): 921-929
Published online Jul 28, 2017. doi: 10.4254/wjh.v9.i21.921
Published online Jul 28, 2017. doi: 10.4254/wjh.v9.i21.921
Is the 25-year hepatitis C marathon coming to an end to declare victory?
Khulood T Ahmed, Ashraf A Almashhrawi, Jamal A Ibdah, Veysel Tahan, Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO 65212, United States
Author contributions: All authors contributed to the acquisition of data, writing, and revision of this manuscript.
Conflict-of-interest statement: All the authors have no conflicts of interests to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Veysel Tahan, MD, Associate Professor, Division of Gastroenterology and Hepatology, University of Missouri, 1 Hospital Dr, Columbia, MO 65212, United States. tahanv@health.missouri.edu
Telephone: +1-573-8846044 Fax: +1-573-8844595
Received: April 8, 2017
Peer-review started: April 12, 2017
First decision: May 22, 2017
Revised: June 4, 2017
Accepted: July 7, 2017
Article in press: July 10, 2017
Published online: July 28, 2017
Peer-review started: April 12, 2017
First decision: May 22, 2017
Revised: June 4, 2017
Accepted: July 7, 2017
Article in press: July 10, 2017
Published online: July 28, 2017
Core Tip
Core tip: Spreading awareness about the need for screening and treatment of hepatitis C virus (HCV) will help identifying more cases to provide appropriate treatment. As more direct-acting agents are coming out of the pipeline, healthcare managers will face the major task of making those medicines available to HCV-infected patients. One of the efforts, successfully dismantling some of those barriers is the Extended Community Healthcare Outcomes project. Finally, efforts toward developing effective vaccines should be boosted as history tells us that most of success stories in eradicating infectious illness were made possible largely because of vaccines against the offending pathogen.